metricas
covid
Medicina Clínica (English Edition) Use of tocilizumab as a therapeutic option for hereditary apolipoprotein AI-asso...
Journal Information

Statistics

Follow this link to access the full text of the article

Letter to the Editor
Use of tocilizumab as a therapeutic option for hereditary apolipoprotein AI-associated amyloidosis
Uso de tocilizumab como opción terapéutica en la amiloidosis hereditaria asociada a apolipoproteína A-I
Luis Luque Caraballoa,
Corresponding author
luis.luque11@gmail.com

Corresponding author.
, Manuel Garrido Montesa,b, José Salvador García Morilloa,b
a Department of Internal Medicine, Virgen del Rocío University Hospital, Seville, Spain
b Unit of Systemic and Rare Autoimmune Diseases in Adults, Virgen del Rocío University Hospital, Seville, Spain
Read
10
Times
was read the article
0
Total PDF
10
Total HTML
Share statistics
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 10 0 10

Follow this link to access the full text of the article